About the LGR

A world-class engine for advancing functional genomics, translating cutting-edge genomic science into scalable, high-impact biological discovery.

Background ShapeBackground Shape

46

Principal Investigators

31

Research Projects

52

Published Papers

112k

Samples Tested

Get to know us

The Laboratory for Genomics Research (LGR) is a state-of-the-art functional genomics center located near the UCSF Mission Bay campus. We have built a fully integrated, end-to-end CRISPR screening facility with deep expertise spanning automation, next-generation sequencing, computational analysis, and cell biology.

Our work advances functional genomics tool development and applies these technologies to uncover mechanisms of human disease biology. By combining large-scale screening with rigorous biological investigation, we generate insights that expand understanding of disease and accelerate therapeutic discovery.

As we continue to grow, our focus is on expanding disease area knowledge, advancing CRISPR-based technologies, and serving as a resource to the broader scientific community.
Background Shape

Our Foundation

The Laboratory for Genomics Research (LGR) was established through a collaboration between UC Berkeley and UC San Francisco, in partnership with GSK. Its founding vision brought together leaders who shaped the field: Jennifer Doudna, co-inventor of CRISPR and Nobel Laureate; Jonathan Weissman, a pioneer of CRISPR screening technologies; and Hal Barron, former Chief Scientific Officer of GSK.

Throughout this partnership, we have established a strong foundation in functional genomics by building and applying advanced tools and platforms across diverse disease areas. Through these efforts, we have supported numerous research programs and contributed to high-impact publications and patented innovations that enable new approaches to studying genome function and disease.

Where We Are Today

Today, LGR is a UCSF-based genomics organization advancing CRISPR technologies and enabling collaborative research across academia, industry, and philanthropic partnerships. We develop and apply next-generation functional genomics approaches across diverse disease areas, supporting both large-scale programs and independent research, and offering flexible, end-to-end capabilities from experimental design through data generation and analysis. Together, these capabilities enable us to accelerate discovery while continuing to drive innovation in the field.
Partner With Us

Our Vision for the Future

To transform our understanding of genome function in health and disease through building world-class functional genomics tools, standardizing approaches for robust data generation, and deploying infrastructure that enables large-scale experimentation—driving the discovery of high-confidence therapeutic targets.

The LGR is focused on building new partnerships that expand our ability to address critical challenges in science and health, leveraging collective expertise to achieve breakthroughs that benefit all. Join us in shaping the next era of functional genomics
Background Shape
Background Shape

Accomplishments To Date

  • January 2021: Built and validated core suite of CRISPRi/a cell lines
  • March 2021: Computational pooled screen analysis pipeline deployed
  • July 2021: First in-house FACS-based screen completed
  • August 2021: Arrayed Screening platform build completed
  • August 2021: Generation of transferable genome-wide CRISPRi library
  • October 2021: First single cell functional genomics screen completed
Background ShapeBackground Shape

Our Roadmap

PAST

May 2019:
Collaboration agreement signed

October 2019:
Inaugural LGR symposium

April 2020:
First wave of university-funded projects to support Covid research

July 2020:
First collaborative project initiated

October 2020:
First genome-wide screen completed

PRESENT

August 2021:
SOMETHING ABOUT AUTOMATION EQUIPMENT / THERMO SYSTEM

FUTURE

[Date]
Transferable CRISPRi library

[Date]
Computational pipeline?

[Date]
Staffing %

Our Goals

  • Build advanced CRISPR-based genome editing and functional genomics platforms that are enhanced by human genetics and computational biology
  • Discover novel drug targets with high probability of success and expand our knowledge of the human genome in various disease contexts
  • Innovate and industrialize CRISPR functional genomics to provide world-class technology solutions and research tools to UC, GSK, and the broader scientific community.
Background Shape
Background Shape
Joining forces to advance genomic research and improve drug discovery
Learn more about who we are, what we do, and why we do it.

The Start

The LGR is the brainchild of Professor Jennifer Doudna, UCB, a co-inventor of CRISPR technology and HHMI Investigator, 2020 Nobel Prize Laureate in Chemistry; Professor Jonathan Weissman, UCSF, a pioneer of CRISPR screening technology and HHMI Investigator; and Dr. Hal Barron, Former Chief Scientific Officer and President, R&D, GSK. The five-year collaboration to establish a state-of-the-art laboratory for CRISPR technologies was announced in June 2019. Since our founding, we have set in motion several collaborative projects between UC & GSK across different disease areas as well as funded multiple independent university research projects at both UCSF and UC Berkeley.
See our projects
Background ShapeBackground Shape

Our Founders

Jennifer Doudna
CRISPR Co-Inventor, 2020 Nobel Prize Laureate in Chemistry, UC Berkeley Professor of Biochemistry, Biophysics & Structural biology, HHMI Investigator
Read Bio
Jeremy Reiter
UCSF physician-scientist and HHMI Investigator whose research focuses on cilia biology and its implications in human disease.
Read Bio
Fyodor Urnov
Gene editing pioneer at UC Berkeley & the Innovative Genomics Institute (IGI), advancing CRISPR technologies for therapeutic applications.
Read Bio
Background Shape

Partners

UCSF Logo
UC San Francisco (UCSF) is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care.
GSK Logo
GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. At GSK, we’re bringing together great science, new tech, and outstanding people with the goal of doubling our development success rate to make a difference in more patients’ lives.
UC Berkeley Logo
UCB is the world’s premier public university with a mission to excel in teaching, research and public service. This mission has led to the university's distinguished record of world-class scholarship, innovation, concern for the betterment of our world, and top rankings for its schools and departments.
Partner With Us

Build what’s next in functional genomics.